122 related articles for article (PubMed ID: 3511982)
21. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
[TBL] [Abstract][Full Text] [Related]
22. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting.
Klingemann HG; Tsoi MS; Storb R
Blood; 1986 Jul; 68(1):102-7. PubMed ID: 2941083
[TBL] [Abstract][Full Text] [Related]
24. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
25. ELISA detection of specific functional antibodies in human serum to Escherichia coli, tetanus toxoid, and diphtheria-tetanus toxoids: normal values for IgG, IgA, and IgM.
Moen RC; Oemichen SL; Kiggens AJ; Hong R
Diagn Immunol; 1986; 4(1):17-23. PubMed ID: 3514070
[TBL] [Abstract][Full Text] [Related]
26. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
Tsoi MS; Storb R; Weiden PL; Thomas ED
J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
[TBL] [Abstract][Full Text] [Related]
27. Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation.
Winkler J; Tittlbach H; Schneider A; Buchstaller C; Mayr A; Vasova I; Roesler W; Mach M; Mackensen A; Winkler TH
Ann Hematol; 2020 Aug; 99(8):1895-1906. PubMed ID: 32519092
[TBL] [Abstract][Full Text] [Related]
28. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients.
Gratama JW; Oosterveer MA; Lepoutre JM; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Richel D; Klein G; Ernberg I
Transplantation; 1990 Apr; 49(4):725-30. PubMed ID: 2158159
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo immune response to specific antigens in canine marrow graft recipients.
Abb J; Kolb HJ; Rodt HV; Grosse-Wilde H; Rieder I; Thierfelder S
Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):152-61. PubMed ID: 71795
[TBL] [Abstract][Full Text] [Related]
30. Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.
Benkerrou M; Wara DW; Elder M; Dror Y; Merino A; Colombe BW; Garovoy M; Cowan MJ
J Clin Immunol; 1994 Mar; 14(2):98-106. PubMed ID: 8195318
[TBL] [Abstract][Full Text] [Related]
31. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
Kodo H; Gale RP; Saxon A
J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
[TBL] [Abstract][Full Text] [Related]
32. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.
Hammarström V; Pauksen K; Azinge J; Oberg G; Ljungman P
Support Care Cancer; 1993 Jul; 1(4):195-9. PubMed ID: 8193881
[TBL] [Abstract][Full Text] [Related]
33. Immunologic response to early and routine DTP immunization in infants.
Baraff LJ; Leake RD; Burstyn DG; Payne T; Cody CL; Manclark CR; St Geme JW
Pediatrics; 1984 Jan; 73(1):37-42. PubMed ID: 6318185
[TBL] [Abstract][Full Text] [Related]
34. Human/mouse radiation chimera are capable of mounting a human primary humoral response.
Marcus H; David M; Canaan A; Kulova L; Lubin I; Segall H; Denes L; Erlich P; Galun E; Gan J
Blood; 1995 Jul; 86(1):398-406. PubMed ID: 7795248
[TBL] [Abstract][Full Text] [Related]
35. Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease.
Brkic S; Tsoi MS; Mori T; Lachman L; Gillis S; Thomas ED; Storb R
Transplantation; 1985 Jan; 39(1):30-5. PubMed ID: 3880962
[TBL] [Abstract][Full Text] [Related]
36. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
Lum LG; Culbertson NJ
J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
[TBL] [Abstract][Full Text] [Related]
37. IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.
Lum LG; Burns E; Janson MM; Martin PJ; Giddings BR; Seigneuret MC; Noges JE; Galoforo SC
J Clin Immunol; 1990 Sep; 10(5):255-64. PubMed ID: 2176226
[TBL] [Abstract][Full Text] [Related]
38. B cell development and regulation after T cell-depleted marrow transplantation.
Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
[TBL] [Abstract][Full Text] [Related]
39. Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease.
Witherspoon RP; Matthews D; Storb R; Atkinson K; Cheever M; Deeg HJ; Doney K; Kalbfleisch J; Noel D; Prentice R
Transplantation; 1984 Feb; 37(2):145-50. PubMed ID: 6420960
[TBL] [Abstract][Full Text] [Related]
40. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
